Navigation Links
Need for Hepatitis Booster Questioned

British researchers suggest booster vaccinations for hepatitis A may not really be necessary. Studies done indicate people who receive the HAV vaccine develop immune memory of the virus long after// detectable levels of antibodies to the virus can been measured.

Hepatitis A is common around the world, with about 1.4 million new cases identified each year. The incidence of the disease is lowest in developed countries, where vaccination programs have been in place for 10 years.

Vaccination could also protect people in less developed countries, but many are not receiving the shots, which are usually given in three doses. Now that researchers have been able to study the vaccine for a decade, they’re finding people with healthy immune systems continue to have protective antibodies. What’s more, these individuals also develop underlying immune memory, which is likely to provide continued protection, suggesting there may be no need for booster shots. Some studies have even shown one dose of the initial vaccine may be sufficient to protect people long term.

The findings hold important implications for public health in under-developed countries, where a single course of vaccination would make it easier to protect more people.

Researchers say If HAV booster vaccinations are not needed ... then universal vaccination of children living in areas of intermediate endemicity might prove more attractive. Not only will this strategy provide long-term protection against hepatitis A extending into adulthood but also it will result in substantial cost-savings through lower vaccination costs.


'"/>




Page: 1

Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Cure for Hepatitis B
4. Hepatitis E virus made impotent
5. Sharing injection equipment spreads Hepatitis C
6. Lymphomas Link to Hepatitis C
7. Hepatitis shots is promising
8. Good News for HIV Patients Also Suffering From Hepatitis C Virus
9. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
10. The Effectiveness Of Hepatitis B Vaccine Questioned
11. New Treatment for Chronic Hepatitis B
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... 04, 2016 , ... Trinity Health today launched its inaugural ... aimed at improving care and reducing readmission rates for patients who are dually ... Health is to drive innovation that transforms our ministry and our industry to ...
(Date:5/4/2016)... SCOTTSDALE, AZ (PRWEB) , ... May 04, 2016 ... ... 2016 Annual Technology & Business Conference. The conference opened on Tuesday with Frank ... panel discussion on NCPDP’s PDMP Solution provided a deep dive on NCPDP’s model ...
(Date:5/4/2016)... ... ... Level 10 Head Over Heels Athletic Arts’ gymnast Alessandra Brovedani -- who goes ... fall of 2019. , After a handful of college visits, the Berkeley High ... her connection with the coaching staff and the excitement surrounding Wildcat Athletics. , “What ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... therapy products, announced today the introduction of the innovative newly improved Iso-Hip Wrap. ... hip replacement patients. The plush design enhances comfort and enables the patient to ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Nike Rugby Camp's ... rugby in San Diego. Willis, founder of Elite Rugby Camps and current Nike Camp ... players every year since 2009. , “I’m excited for our eighth summer here ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is ... a video of two patients who tell their personal story and encourage those at risk ... Meet Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... May 3, 2016  Forté Elements, LLC (Forté) is excited to announce the launch ... address the nutritional needs of recovery for a variety of clinical conditions. Founded in ... Photo - http://photos.prnewswire.com/prnh/20160502/362548 Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
(Date:5/2/2016)...  Deerfield announced today it led the $44.5 ... Graybug Vision is an early stage pharmaceutical company ... for ocular diseases including wet age-related macular degeneration ... developed at Johns Hopkins University and has been ... Graybug Vision is developing ophthalmology products enabling ...
Breaking Medicine Technology: